Double Blind, Double Dummy, Randomized, Placebo-controlled, 5 Period Cross-over Study To Examine The Effect Of PF-05089771 Alone And In Combination With Pregabalin On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin And Ibuprofen As Positive Controls

Trial Profile

Double Blind, Double Dummy, Randomized, Placebo-controlled, 5 Period Cross-over Study To Examine The Effect Of PF-05089771 Alone And In Combination With Pregabalin On Evoked Pain Endpoints In Healthy Volunteers Using Pregabalin And Ibuprofen As Positive Controls

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Apr 2015

At a glance

  • Drugs PF 5089771 (Primary)
  • Indications Neuropathic pain; Pain
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 22 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 03 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
    • 04 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top